Figure 2 from Treatment and Outcome of Hemorrhagic Transformation After Intravenous Alteplase in Acute Ischemic Stroke: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association | Semantic Scholar
The illustration of the fibrinolytic mechanisms: (a) tissue plasminogen... | Download Scientific Diagram
Therapeutics targeting the fibrinolytic system | Experimental & Molecular Medicine
Molecular mechanisms of plasminogen activation: bacterial cofactors provide clues: Trends in Biochemical Sciences
tPA Mobilizes Immune Cells That Exacerbate Hemorrhagic Transformation in Stroke | Circulation Research
Plasminogen activator - Wikipedia
Thrombolytic Activity, Drug Likeness Property and ADME/T Analysis of Isolated Phytochemicals from Ginger (Zingiber officinale) Using In Silico Approaches
Recombinant tissue plasminogen activators (rtPA): A review - Gurman - 2015 - Clinical Pharmacology & Therapeutics - Wiley Online Library
Mechanism of action of TXA. Profibrinolytic effects are in green, and... | Download Scientific Diagram
Fibrinogen-mimicking, multiarm nanovesicles for human thrombus-specific delivery of tissue plasminogen activator and targeted thrombolytic therapy | Science Advances
Alteplase or tenecteplase for thrombolysis in ischemic stroke: An illustrated review - Zhu - 2022 - Research and Practice in Thrombosis and Haemostasis - Wiley Online Library
Cathflo® Activase® (alteplase) Mechanism of Action
Unveiling an exceptional zymogen: the single-chain form of tPA is a selective activator of NMDA receptor-dependent signaling and neurotoxicity | Cell Death & Differentiation
Thrombolytics | Concise Medical Knowledge
Identification and Characterization of Plasmin-Independent Thrombolytic Enzymes | Circulation Research